- LatestSpecific HAART regimens 'not linked to more severe mental illnesses in youth'
- LatestStem cell researchers make headway in building infant hearts
- LatestEradication of female genital mutilation "a matter of resources"
- LatestFIGO supports 2012’s International Day of Zero Tolerance to Female Genital Mutilation (6 February 2012)
- LatestAbstract Submission and ‘Early Registration’ fee deadline dates extended for FIGO 2012 World Congress
- LatestApplication process now open: FIGO/Olympus training courses in minimally invasive surgical techniques
Fear 'affects women's cervical cancer screening decision'
A new report has indicated that fear plays a major role in whether women decide to go for cancer screening or not.
Research conducted by US-based Dr Kelly Ackerson and Dr Stephanie Preston also indicates that healthcare providers underestimate how much women need to know about the condition.
Their report claims that doctors wrongly assume women will ask for relevant information if they need it.
Dr Ackerson, an assistant professor at Western Michigan University, USA, stated: "Some women complied because they feared the disease and saw screening as routine care, but other women feared medical examinations, healthcare providers, tests and procedures and didn't seek screening if their health was good."
She added that a lack of information was a big barrier to some women seeking screening, with very few understanding that cervical smear testing aims to identify abnormal cells before they become malignant.
Earlier this month, the World Health Organization granted pre-qualification status to Gardasil - a four-type human papillomavirus vaccine created by Merck Vaccines and Infectious Diseases.


![Sift.com [Opens in a new window]](/sites/www.figo.org/themes/figocorp/images/footer-sift-logo.gif)